An interesting point from Krugman:

Take the CBO estimate of the cost of subsidies and Medicaid expansion in the Senate bill that is, ignoring all possible cost savings. It’s $179 billion in 2018. Take the CMS projection of total health care spending in 2018: it’s more than $4.5 trillion. So the direct cost of expanding coverage the initial bump in the blue curve above is less than 4 percent of total health care spending. That’s the amount by which, on the current trajectory, health spending rises every 7 months.

And it's budgeted. Any Republican who voted for the unfunded Medicare Prescription Drug Entitlement has no logical standing to oppose this bill on fiscal grounds.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.